Pulsenmore (PLSM) Cash & Equivalents (2025)
Pulsenmore (PLSM) reported Cash & Equivalents of $6.8 million for Q4 2025.
Pulsenmore (PLSM) Cash & Equivalents (2025) Analysis & Trends
Pulsenmore (PLSM) has 1 years of Cash & Equivalents data on file, last reported at $6.8 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents changed N/A year-over-year to $6.8 million; the trailing twelve-month figure through Dec 2025 stood at $6.8 million (changed N/A YoY), and the FY2025 full-year result was $6.8 million, changed N/A from the prior year.
- Cash & Equivalents steadied at $6.8 million in Q4 2025.
- In the past five years, Cash & Equivalents ranged from a high of $6.8 million in Q4 2025 to a low of $6.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Pulsenmore | 23.58 Mn | 1.91 Mn | - | 6.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.77 Mn |